Precision NanoSystems
12:30 PM - 12:45 PM (EDT), Thursday, June 8, 2023 ・ Session Room 104A
Precision NanoSystems, now part of the Danaher Life Sciences platform, is a global leader in ushering in the next wave of genomic medicines for infectious diseases, cancer, and rare diseases. Collaborating with the world’s leading drug developers to understand disease and create the therapeutics that will define the future of medicine, Precision NanoSystems offers non-viral delivery solutions, including NanoAssemblr®️ lipid nanoparticle (LNP) formulation instruments, a proprietary ionizable lipid library, off-the-shelf reagents, and biopharma services.
Ticker:
DHR
Exchange:
NYSE
Company Type:
Not Provided
Company Website:
Company HQ State:
British Columbia
Company HQ Country:
Canada
Year Founded:
2010
Main Therapeutic Focus:
Platform for Therapeutics
Lead Product in Development:
N/A. Biotech Platform Company.
Development Phase of Primary Product:
Other/Not Applicable
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
